APA (7th ed.) Citation

R. O. Shcherbyna, O. V. Khromylova, H. R. Nimenko, & V. O. Salionov. (2024). Development of the optimal composition of tablets with the active substance potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the effect of auxiliary substances on bulk density, bulk density after shrinkage, fluidity and angle of natural slope of powder masses. Zaporozhye State Medical University.

Chicago Style (17th ed.) Citation

R. O. Shcherbyna, O. V. Khromylova, H. R. Nimenko, and V. O. Salionov. Development of the Optimal Composition of Tablets with the Active Substance Potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the Effect of Auxiliary Substances on Bulk Density, Bulk Density After Shrinkage, Fluidity and Angle of Natural Slope of Powder Masses. Zaporozhye State Medical University, 2024.

MLA (9th ed.) Citation

R. O. Shcherbyna, et al. Development of the Optimal Composition of Tablets with the Active Substance Potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate. Message 1. Study of the Effect of Auxiliary Substances on Bulk Density, Bulk Density After Shrinkage, Fluidity and Angle of Natural Slope of Powder Masses. Zaporozhye State Medical University, 2024.